Lv21
140 积分 2023-06-04 加入
抗TNF-α生物制剂对强直性脊柱炎患者不同证型的影响
6小时前
待确认
生物制剂治疗强直性脊柱炎的长期疗效观察
6小时前
已完结
Enthesitis: from pathophysiology to treatment
1天前
已完结
Xeligekimab: First Approval
17天前
已完结
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
17天前
已完结
Iptacopan: First Approval
18天前
已完结
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial
21天前
已完结
Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
28天前
已完结
Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
28天前
已完结
Paroxysmale nächtliche Hämoglobinurie (PNH)
1个月前
已完结
皖公网安备34019202002308
